Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brachytherapy | 8 | 2025 | 85 | 1.690 |
Why?
|
| Radiosurgery | 4 | 2021 | 148 | 0.830 |
Why?
|
| Iodine Radioisotopes | 3 | 2025 | 65 | 0.640 |
Why?
|
| Radiometry | 3 | 2019 | 49 | 0.640 |
Why?
|
| Uveal Neoplasms | 3 | 2025 | 32 | 0.630 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2010 | 107 | 0.570 |
Why?
|
| Melanoma | 3 | 2025 | 927 | 0.390 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2025 | 1265 | 0.370 |
Why?
|
| Rectum | 2 | 2025 | 102 | 0.360 |
Why?
|
| Prostatic Neoplasms | 3 | 2025 | 1406 | 0.330 |
Why?
|
| Radiation Dosage | 1 | 2010 | 131 | 0.310 |
Why?
|
| Artifacts | 1 | 2010 | 99 | 0.300 |
Why?
|
| Radiotherapy Dosage | 5 | 2025 | 217 | 0.300 |
Why?
|
| Phantoms, Imaging | 2 | 2019 | 141 | 0.220 |
Why?
|
| Glaucoma, Neovascular | 1 | 2023 | 2 | 0.210 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2024 | 85 | 0.200 |
Why?
|
| Radiation Pneumonitis | 1 | 2023 | 11 | 0.200 |
Why?
|
| Models, Biological | 1 | 2008 | 1375 | 0.200 |
Why?
|
| Salvage Therapy | 1 | 2025 | 174 | 0.200 |
Why?
|
| Eye Injuries | 1 | 2023 | 50 | 0.190 |
Why?
|
| Radiation Injuries | 2 | 2021 | 141 | 0.190 |
Why?
|
| Optic Nerve Diseases | 1 | 2023 | 76 | 0.180 |
Why?
|
| Retinal Diseases | 1 | 2023 | 142 | 0.180 |
Why?
|
| Algorithms | 1 | 2008 | 1662 | 0.170 |
Why?
|
| Tooth Abnormalities | 1 | 2021 | 13 | 0.170 |
Why?
|
| Xerostomia | 1 | 2021 | 12 | 0.170 |
Why?
|
| Salivary Glands | 1 | 2021 | 35 | 0.170 |
Why?
|
| Thymoma | 1 | 2021 | 19 | 0.170 |
Why?
|
| Scintillation Counting | 1 | 2019 | 7 | 0.150 |
Why?
|
| Plastics | 1 | 2019 | 13 | 0.150 |
Why?
|
| Hospitals, Religious | 1 | 2018 | 6 | 0.140 |
Why?
|
| Robotic Surgical Procedures | 1 | 2022 | 224 | 0.140 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 31 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 479 | 0.140 |
Why?
|
| Radiation Oncology | 1 | 2018 | 29 | 0.130 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 2597 | 0.130 |
Why?
|
| Disaster Planning | 1 | 2018 | 68 | 0.130 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2018 | 101 | 0.130 |
Why?
|
| Cancer Survivors | 1 | 2021 | 273 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 1305 | 0.130 |
Why?
|
| Cyclonic Storms | 1 | 2018 | 82 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 635 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1547 | 0.100 |
Why?
|
| Humans | 16 | 2025 | 130085 | 0.090 |
Why?
|
| Aged | 6 | 2025 | 20821 | 0.080 |
Why?
|
| Film Dosimetry | 1 | 2010 | 2 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2010 | 39 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 79 | 0.080 |
Why?
|
| Photons | 1 | 2010 | 60 | 0.080 |
Why?
|
| Body Burden | 1 | 2008 | 3 | 0.070 |
Why?
|
| Brain | 1 | 2021 | 3146 | 0.070 |
Why?
|
| Equipment Design | 1 | 2010 | 509 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 1212 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2010 | 358 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 6765 | 0.070 |
Why?
|
| Middle Aged | 5 | 2025 | 28314 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2025 | 12821 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17541 | 0.060 |
Why?
|
| Organs at Risk | 1 | 2025 | 48 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2008 | 668 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2076 | 0.060 |
Why?
|
| Appointments and Schedules | 1 | 2024 | 48 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2024 | 55 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2025 | 222 | 0.050 |
Why?
|
| Vitreous Hemorrhage | 1 | 2023 | 7 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2891 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2025 | 304 | 0.050 |
Why?
|
| Workload | 1 | 2024 | 150 | 0.050 |
Why?
|
| Male | 6 | 2025 | 64386 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2023 | 66 | 0.050 |
Why?
|
| Aminopyridines | 1 | 2023 | 63 | 0.050 |
Why?
|
| Cadaver | 1 | 2022 | 114 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 2023 | 155 | 0.050 |
Why?
|
| Cystectomy | 1 | 2022 | 142 | 0.040 |
Why?
|
| Female | 5 | 2025 | 70246 | 0.040 |
Why?
|
| Etoposide | 1 | 2021 | 111 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2021 | 56 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 631 | 0.040 |
Why?
|
| Necrosis | 1 | 2021 | 193 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 549 | 0.040 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 126 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2022 | 820 | 0.040 |
Why?
|
| Quality Control | 1 | 2019 | 116 | 0.040 |
Why?
|
| Cisplatin | 1 | 2021 | 274 | 0.040 |
Why?
|
| Protestantism | 1 | 2018 | 4 | 0.030 |
Why?
|
| Hospital Administration | 1 | 2018 | 23 | 0.030 |
Why?
|
| Floods | 1 | 2018 | 21 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 31011 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 272 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 902 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1531 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1069 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2822 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 1278 | 0.030 |
Why?
|
| Texas | 1 | 2018 | 3655 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6165 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10960 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 15005 | 0.010 |
Why?
|
| Child | 1 | 2021 | 26174 | 0.010 |
Why?
|